FDA approves a new cancer drug targeted to genetic mutation, not cancer type - https://t.co/LULgPfXrPx https://t.co/HNLMlqcciP — IDRO (@IDROOhio) November 29, 2018
FDA approves a new cancer drug targeted to genetic mutation, not cancer type - https://t.co/LULgPfXrPx https://t.co/HNLMlqcciP
No comments:
Post a Comment